Tilray Brands, Inc. Compensation Expense, Excluding Cost of Good and Service Sold
Tilray Brands, Inc. (TLRY) reported Compensation Expense, Excluding Cost of Good and Service Sold of $15.60 million for the 12-month period ending 2024-05-31, per its 10-K filed 2024-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CompensationExpenseExcludingCostOfGoodAndServiceSold · last filed 2024-10-10
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for the quarter ending 2024-05-31 was $10.84M, a 152.33% increase year-over-year.
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for the quarter ending 2024-02-29 was $1.58M, a 42.45% decline year-over-year.
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for the quarter ending 2023-11-30 was $3.32M, a 8.98% increase year-over-year.
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for the quarter ending 2023-08-31 was $3.66M, a 2.98% increase year-over-year.
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for fiscal 2024 was $15.60M, a 14.22% increase from fiscal 2023.
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for fiscal 2023 was $13.65M, a 3.35% decline from fiscal 2022.
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for fiscal 2022 was $14.13M, a 63.42% increase from fiscal 2021.
- Tilray Brands, Inc. compensation expense, excluding cost of good and service sold for fiscal 2021 was $8.64M, a 27.56% increase from fiscal 2020.
| Period end | Compensation Expense, Excluding Cost of Good and Service Sold 3 month | Compensation Expense, Excluding Cost of Good and Service Sold 6 month | Compensation Expense, Excluding Cost of Good and Service Sold 9 month | Compensation Expense, Excluding Cost of Good and Service Sold 12 month |
|---|---|---|---|---|
| 2024-05-31 | $10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $12.43M derived: sum of 2 quarters · filed 2024-07-30 | $15.75M derived: sum of 3 quarters · filed 2024-07-30 | $15.60M 10-K · filed 2024-07-30 |
| 2024-02-29 | $1.58M 10-Q · filed 2024-04-09 | $4.91M derived: sum of 2 quarters · filed 2024-04-09 | $4.76M 10-Q · filed 2024-04-09 | $12.87M derived: sum of 4 quarters · filed 2024-10-10 |
| 2023-11-30 | $3.32M 10-Q · filed 2024-01-09 | $6.99M 10-Q · filed 2024-01-09 | $11.28M derived: sum of 3 quarters · filed 2024-10-10 | $14.04M derived: sum of 4 quarters · filed 2024-10-10 |
| 2023-08-31 | $3.66M 10-Q · filed 2024-10-10 | $7.96M derived: sum of 2 quarters · filed 2024-10-10 | $10.71M derived: sum of 3 quarters · filed 2024-10-10 | $13.76M derived: sum of 4 quarters · filed 2024-10-10 |
| 2023-05-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $7.05M derived: sum of 2 quarters · filed 2024-07-30 | $10.10M derived: sum of 3 quarters · filed 2024-07-30 | $13.65M 10-K · filed 2024-07-30 |
| 2023-02-28 | $2.75M 10-Q · filed 2024-04-09 | $5.80M derived: sum of 2 quarters · filed 2024-04-09 | $9.36M 10-Q · filed 2024-04-09 | $13.92M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | $3.05M 10-Q · filed 2024-01-09 | $6.61M 10-Q · filed 2024-01-09 | $11.17M derived: sum of 3 quarters · filed 2024-10-10 | $15.41M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | $3.56M 10-Q · filed 2024-10-10 | $8.12M derived: sum of 2 quarters · filed 2024-10-10 | $12.36M derived: sum of 3 quarters · filed 2024-10-10 | $14.59M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $8.80M derived: sum of 2 quarters · filed 2024-07-30 | $11.04M derived: sum of 3 quarters · filed 2024-07-30 | $14.13M 10-K · filed 2024-07-30 |
| 2022-02-28 | $4.24M 10-Q · filed 2023-04-10 | $6.47M derived: sum of 2 quarters · filed 2023-04-10 | $9.56M 10-Q · filed 2023-04-10 | $11.33M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | $2.24M 10-Q · filed 2023-01-09 | $5.33M 10-Q · filed 2023-01-09 | $7.09M derived: sum of 3 quarters · filed 2023-07-26 | $9.01M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | $3.09M 10-Q · filed 2022-10-07 | $4.86M derived: sum of 2 quarters · filed 2023-07-26 | $6.77M derived: sum of 3 quarters · filed 2023-07-26 | $9.48M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-05-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $3.68M derived: sum of 2 quarters · filed 2023-07-26 | $6.39M derived: sum of 3 quarters · filed 2023-07-26 | $8.64M 10-K · filed 2023-07-26 |
| 2021-02-28 | $1.92M 10-Q · filed 2022-04-06 | $4.63M derived: sum of 2 quarters · filed 2022-04-06 | $6.88M 10-Q · filed 2022-04-06 | |
| 2020-11-30 | $2.71M 10-Q · filed 2022-01-10 | $4.96M 10-Q · filed 2022-01-10 | ||
| 2020-08-31 | $2.25M 10-Q · filed 2021-10-07 | |||
| 2020-05-31 | $6.78M 10-K · filed 2022-07-28 | |||
| 2019-05-31 | $4.40M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |